Jump to content

Pharmacogenomics (journal)

From Wikipedia, the free encyclopedia
Pharmacogenomics
Cover
DisciplinePharmacogenomics
LanguageEnglish
Edited byDavid Gurwitz, Howard McLeod, Munir Pirmohamed
Publication details
History2000–present
Publisher
Frequency18/year
2.350 (2016)
Standard abbreviations
ISO 4Pharmacogenomics
Indexing
CODENPARMFL
ISSN1462-2416 (print)
1744-8042 (web)
OCLC no.55059877
Links

Pharmacogenomics is a peer-reviewed medical journal established in 2000 and published by Future Medicine. The editors-in-chief are David Gurwitz (Tel-Aviv University), Howard McLeod (University of North Carolina at Chapel Hill), and Munir Pirmohamed (University of Liverpool). The journal covers the field of pharmacogenomics.

Abstracting and indexing

[edit]

The journal is abstracted and indexed in Biological Abstracts, BIOSIS Previews, Biotechnology Citation Index, Chemical Abstracts, Current Contents/Life Sciences, EMBASE/Excerpta Medica, Index Medicus/MEDLINE/PubMed, Science Citation Index, and Scopus. According to the Journal Citation Reports, the journal has a 2016 impact factor of 2.350, ranking it 132nd out of 256 journals in the category "Pharmacology & Pharmacy".[1]

References

[edit]
  1. ^ "Journals Ranked by Impact: Pharmacology & Pharmacy". 2016 Journal Citation Reports. Web of Science (Science ed.). Thomson Reuters. 2017.
[edit]